Cisplatin and etoposide or temozolomide and capecitabine in treating patients with neuroendocrine carcinoma of the gastrointestinal tract or pancreas that is metastatic or cannot be removed by surgery Meeting Abstract


Authors: Eads, J. R.; Catalano, P.; Fisher, G. A.; Klimstra, D.; Zhang, Z.; Rubin, D.; Iagaru, A.; Wong, T. Z.; O'Dwyer, P.
Abstract Title: Cisplatin and etoposide or temozolomide and capecitabine in treating patients with neuroendocrine carcinoma of the gastrointestinal tract or pancreas that is metastatic or cannot be removed by surgery
Meeting Title: 9th Annual Meeting of the North American NeuroEndocrine Tumor Society (NANETS)
Journal Title: Pancreas
Volume: 46
Issue: 3
Meeting Dates: 2016 Sep 29-Oct 1
Meeting Location: Jackson Hole, WY
ISSN: 0885-3177
Publisher: Lippincott Williams & Wilkins  
Date Published: 2017-03-01
Start Page: 451
Language: English
ACCESSION: WOS:000394448600112
PROVIDER: wos
DOI: 10.1097/MPA.0000000000000812
Notes: Meeting Abstract -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. David S Klimstra
    978 Klimstra